Curis
CRIS
#11076
Rank
ยฃ3.1 M
Marketcap
ยฃ0.33
Share price
-9.03%
Change (1 day)
-62.22%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -ยฃ6.55 Million

According to Curis's latest financial reports the company's current earnings are ยฃ4.31 Million. In 2025 the company made an earning of -ยฃ4.13 Million, an increase over its 2024 earnings that were of -ยฃ32.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ6.55 Million58.76%
2025 -ยฃ4.13 Million-87.38%
2024 -ยฃ32.69 Million-5.77%
2023 -ยฃ34.69 Million-13.1%
2022 -ยฃ39.92 Million27.52%
2021 -ยฃ31.31 Million65.09%
2020 -ยฃ18.97 Million-9.1%
2019 -ยฃ20.86 Million-4.73%
2018 -ยฃ21.9 Million-41.95%
2017 -ยฃ37.72 Million-14.37%
2016 -ยฃ44.05 Million3.55%
2015 -ยฃ42.53 Million271.52%
2014 -ยฃ11.45 Million76.64%
2013 -ยฃ6.49 Million
2011 -ยฃ5.51 Million27.76%
2010 -ยฃ4.31 Million-43.87%
2009 -ยฃ7.68 Million-23.44%
2008 -ยฃ10.03 Million56.66%
2007 -ยฃ6.4 Million-16.71%
2006 -ยฃ7.69 Million-36.92%
2005 -ยฃ12.19 Million156.25%
2004 -ยฃ4.76 Million-37.24%
2003 -ยฃ7.58 Million-93.34%
2002 -ยฃ0.12 Billion86.79%
2001 -ยฃ60.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ5.32 B-82,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.65 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ47.29 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.81 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.25 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ17.01 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ0.15 Billion 2,203.50%๐Ÿ‡บ๐Ÿ‡ธ USA